EV/EBITDA:
-15.51+0.85(+5.20%)Summary
- As of today (July 1, 2025), AKRO EV/EBITDA is -15.51, with a rise of +0.85 (+5.20%) during the most recent trading session on June 30, 2025.
- Over the past year, AKRO EV/EBITDA has dropped by -8.77 (-130.12%).
- AKRO EV/EBITDA is now -1225.64% below its all-time high of -1.17.
Performance
AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.2% | -5.2% | -5.0% |
| 1 m1 month | -7.8% | +7.8% | +7.5% |
| 3 m3 months | -23.9% | +32.5% | +24.9% |
| 6 m6 months | -116.0% | +145.5% | +90.8% |
| ytdytd | -129.8% | +146.0% | +91.8% |
| 1 y1 year | -130.1% | +204.5% | +127.5% |
| 5 y5 years | -46.0% | +529.9% | +114.1% |
AKRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -14.39 | -7.8% | -16.39 | +5.4% |
| 3 m | 3-month | -9.69 | -60.1% | -16.39 | +5.4% |
| 6 m | 6-month | -5.17 | -200.0% | -16.39 | +5.4% |
| 1 y | 1-year | -5.17 | -200.0% | -16.39 | +5.4% |
| 3 y | 3-year | -1.71 | -807.0% | -26.86 | +42.3% |
| 5 y | 5-year | -1.17 | -1225.6% | -26.86 | +42.3% |
| alltime | all time | -1.17 | -1225.6% | -38.76 | +60.0% |
AKRO EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -15.51(+129.8%) |
| 2024 | -6.75(-8.7%) |
| 2023 | -7.39(-64.7%) |
| Date | Value |
|---|---|
| 2022 | -20.92(+257.6%) |
| 2021 | -5.85(-34.0%) |
| 2020 | -8.87(-28.9%) |
| 2019 | -12.47 |
FAQ
- What is Akero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akero Therapeutics?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics EV/EBITDA year-on-year change?
What is Akero Therapeutics EV/EBITDA?
The current EV/EBITDA of AKRO is -15.51
What is the all time high EV/EBITDA for Akero Therapeutics?
Akero Therapeutics all-time high EV/EBITDA is -1.17
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics EV/EBITDA has changed by -8.76 (-129.78%) since the beginning of the year
What is Akero Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by -8.77 (-130.12%)